J Erin Staples

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Yellow fever: 100 years of discovery
    J Erin Staples
    Arboviral Diseases Branch, Division of Vector Borne Infectious Diseases, Centers for Disease Control and Prevention, 3150 Rampart Rd, Fort Collins, CO 80521, USA
    JAMA 300:960-2. 2008
  2. ncbi request reprint Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    J Erin Staples
    Division of Vector Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, 3150 Rampart Road, MS P 02, Fort Collins, CO 80521, USA
    MMWR Recomm Rep 59:1-27. 2010
  3. doi request reprint Chikungunya fever: an epidemiological review of a re-emerging infectious disease
    J Erin Staples
    Arboviral Diseases Branch, Division of Vector Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    Clin Infect Dis 49:942-8. 2009
  4. pmc Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008
    Michael A Johansson
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico
    Am J Trop Med Hyg 86:349-58. 2012
  5. pmc Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011
    Emily S Jentes
    Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Trop Med Hyg 88:954-61. 2013
  6. pmc Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination
    Katherine B Gibney
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention CDC, Fort Collins, CO 80521, USA
    Am J Trop Med Hyg 87:1112-5. 2012
  7. doi request reprint The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
    Emily S Jentes
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet Infect Dis 11:622-32. 2011
  8. doi request reprint Chikungunya fever in the United States: a fifteen year review of cases
    Katherine B Gibney
    Arboviral Diseases Branch, Division of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
    Clin Infect Dis 52:e121-6. 2011
  9. doi request reprint Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
    Nicole P Lindsey
    Arboviral Diseases Branch, Centers for Disease Control and Prevention, 3150 Rampart Road, Fort Collins, CO 80521, United States
    Vaccine 29:58-64. 2010
  10. pmc Medical risk factors for severe West Nile Virus disease, United States, 2008-2010
    Nicole P Lindsey
    Arboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    Am J Trop Med Hyg 87:179-84. 2012

Collaborators

Detail Information

Publications23

  1. doi request reprint Yellow fever: 100 years of discovery
    J Erin Staples
    Arboviral Diseases Branch, Division of Vector Borne Infectious Diseases, Centers for Disease Control and Prevention, 3150 Rampart Rd, Fort Collins, CO 80521, USA
    JAMA 300:960-2. 2008
  2. ncbi request reprint Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    J Erin Staples
    Division of Vector Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, 3150 Rampart Road, MS P 02, Fort Collins, CO 80521, USA
    MMWR Recomm Rep 59:1-27. 2010
    ..To minimize the risk for serious adverse events, health-care providers should observe the contraindications, consider the precautions to vaccination before administering vaccine, and issue a medical waiver if indicated...
  3. doi request reprint Chikungunya fever: an epidemiological review of a re-emerging infectious disease
    J Erin Staples
    Arboviral Diseases Branch, Division of Vector Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    Clin Infect Dis 49:942-8. 2009
    ....
  4. pmc Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008
    Michael A Johansson
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico
    Am J Trop Med Hyg 86:349-58. 2012
    ..These models could be used to assess the risk of YFV spread during an urban outbreak and identify locations at risk for YFV introduction and subsequent autochthonous transmission...
  5. pmc Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011
    Emily S Jentes
    Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Trop Med Hyg 88:954-61. 2013
    ..To optimize YF vaccine use, clinicians should discuss an individual's risk-benefit assessment of vaccination and close knowledge gaps regarding vaccine use among at-risk populations...
  6. pmc Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination
    Katherine B Gibney
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention CDC, Fort Collins, CO 80521, USA
    Am J Trop Med Hyg 87:1112-5. 2012
    ..Detection of YF IgM antibodies several years postvaccination might reflect remote YF vaccination rather than recent YF vaccination or YF virus infection...
  7. doi request reprint The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
    Emily S Jentes
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet Infect Dis 11:622-32. 2011
    ..This report details the recommendations made by the working group about criteria for the designation of risk and specific changes to the classification of areas with risk for transmission of yellow fever virus...
  8. doi request reprint Chikungunya fever in the United States: a fifteen year review of cases
    Katherine B Gibney
    Arboviral Diseases Branch, Division of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
    Clin Infect Dis 52:e121-6. 2011
    ..Chikungunya virus (CHIKV) represents a threat to the United States, because humans amplify CHIKV and vectors that transmit CHIKV are present...
  9. doi request reprint Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
    Nicole P Lindsey
    Arboviral Diseases Branch, Centers for Disease Control and Prevention, 3150 Rampart Road, Fort Collins, CO 80521, United States
    Vaccine 29:58-64. 2010
    ..There were no reports of encephalitis, meningitis, or Guillain-Barré syndrome. As reported previously, hypersensitivity reactions were common among persons receiving inactivated mouse brain-derived JE vaccine...
  10. pmc Medical risk factors for severe West Nile Virus disease, United States, 2008-2010
    Nicole P Lindsey
    Arboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    Am J Trop Med Hyg 87:179-84. 2012
    ..The only condition independently associated with death was immune suppression. Prevention messages should be targeted to persons with these conditions...
  11. pmc Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010
    Katherine B Gibney
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    Am J Trop Med Hyg 86:895-901. 2012
    ..4; 95% CI = 1.1-5.5). During this outbreak, WNV infection was likely primarily acquired peri-domestically with increased risk associated with potential mosquito larval habitats around the home and neighborhood...
  12. ncbi request reprint Surveillance for human West Nile virus disease - United States, 1999-2008
    Nicole P Lindsey
    Division of Vector Borne Infectious Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, 3150 Rampart Road, Fort Collins, CO 80521, USA
    MMWR Surveill Summ 59:1-17. 2010
    ..Less than 1% of infected persons develop neuroinvasive disease, which typically presents as encephalitis, meningitis, or acute flaccid paralysis...
  13. pmc West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease
    Katherine B Gibney
    Arboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    J Infect Dis 203:344-7. 2011
    ..Prospective studies are needed to determine if and for how long WNV persists in urine following WNV disease...
  14. pmc Incubation periods of Yellow fever virus
    Michael A Johansson
    Centers for Disease Control and Prevention Division of Vector Borne Infectious Diseases, San Juan, Puerto Rico
    Am J Trop Med Hyg 83:183-8. 2010
    ..3-8.6 days). These estimates and their associated statistical models provide a quantitative basis to assist in exposure assessments, model potential outbreaks, and evaluate the effectiveness of public health interventions...
  15. pmc Lack of evidence of increased west nile virus disease severity in the United States in 2012
    Nicole P Lindsey
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado
    Am J Trop Med Hyg 90:163-8. 2014
    ..Despite an increased incidence of neuroinvasive disease in 2012, national surveillance data showed no evidence of changes in epidemiology or increased disease severity compared with the previous 8 years. ..
  16. pmc On the treatment of airline travelers in mathematical models
    Michael A Johansson
    Division of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico
    PLoS ONE 6:e22151. 2011
    ..Models involving travelers can be improved significantly by relatively simple structural changes but also may require further attention to details of parameterization...
  17. doi request reprint West Nile virus disease in children, United States, 1999-2007
    Nicole P Lindsey
    Division of Vector Borne Infectious Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, 3150 Rampart Rd, Fort Collins, CO 80522, USA
    Pediatrics 123:e1084-9. 2009
    ..Although West Nile virus (WNV) disease has occurred predominantly among adults in the United States, children are also susceptible. Epidemiological data describing WNV disease in children are limited...
  18. ncbi request reprint Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Marc Fischer
    Division of Vector Borne Infectious Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Fort Collins, CO 80521, USA
    MMWR Recomm Rep 59:1-27. 2010
    ..JE-MB is the only JE vaccine available for use in children aged 1-16 years, and remaining supplies will be reserved for use in this group...
  19. doi request reprint Influenza-like illness in a community surrounding a school-based outbreak of 2009 pandemic influenza A (H1N1) virus-Chicago, Illinois, 2009
    Kristen B Janusz
    Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA
    Clin Infect Dis 52:S94-101. 2011
    ..Public awareness and health care practices impact standard ILI surveillance data. Community-based surveys are a valuable tool to help assess the burden of ILI in a community...
  20. doi request reprint Adverse event reports following yellow fever vaccination
    Nicole P Lindsey
    Division of Vector Borne Infectious Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
    Vaccine 26:6077-82. 2008
    ....
  21. pmc Pneumonic plague cluster, Uganda, 2004
    Elizabeth M Begier
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 12:460-7. 2006
    ..Person-to-person transmission was compatible with transmission by respiratory droplets, rather than aerosols, and only a few close contacts, all within droplet range, became ill...
  22. doi request reprint Molecular Epidemiology of Francisella tularensis in the United States
    Kiersten J Kugeler
    Centers for Disease Control and Prevention, Division of Vector Borne Infectious Diseases, Fort Collins, Colorado, USA
    Clin Infect Dis 48:863-70. 2009
    ..To verify these findings and to further define differences among genotypes, we performed a large-scale molecular epidemiologic analysis of F. tularensis isolates from humans and animals...
  23. pmc Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004
    J Erin Staples
    Division of Vector Borne Infectious Diseases, Bacterial Zoonoses Branch, Centers for Disease Control and Prevention, Fort Collins, Colorado 80522, USA
    Emerg Infect Dis 12:1113-8. 2006
    ..Through a combined epidemiologic and molecular approach to human cases of tularemia, we provide new insights into the disease for future investigation...